Finally, they indicated that chromosome abnormalities, in particular 19p gain, may underly more aggressive behavior of prolactinoma in men and pointed to the mechanism through which lower expression of ERα in male prolactinomas may increase the transcript level of STAP2 and consequently, through interaction with the STAT signaling pathways, contribute to genome instability and tumor progression [15]. Here, ESR1 is linked to neoplasm.